Review





Similar Products

96
Jackson Immuno rabbit cyanine dye fluorophores 3 18
Rabbit Cyanine Dye Fluorophores 3 18, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyanine-3+dyes/Cy+3+AffiniPure+Donkey+Anti-Rabbit+IgG/pmc13043346-75-23-29
Average 96 stars, based on 1 article reviews
rabbit cyanine dye fluorophores 3 18 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Amersham Life Sciences Inc cyanine 3 dye-labeled streptavidin
Cyanine 3 Dye Labeled Streptavidin, supplied by Amersham Life Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyanine-3+dyes/cy3+labeled+streptavidin/us12313627-1115-29-34
Average 90 stars, based on 1 article reviews
cyanine 3 dye-labeled streptavidin - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Beijing Solarbio Science cyanine dye 3 (cy3)-conjugated phalloidin (f-actin) ca1610
Cyanine Dye 3 (Cy3) Conjugated Phalloidin (F Actin) Ca1610, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyanine-3+dyes/tritc+phalloidin+ca1610/pmc11926226__41467_2025_58059_MOESM1_ESM-84-18-26
Average 90 stars, based on 1 article reviews
cyanine dye 3 (cy3)-conjugated phalloidin (f-actin) ca1610 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

96
Akoya Biosciences red dye tsa cy3
Red Dye Tsa Cy3, supplied by Akoya Biosciences, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyanine-3+dyes/TSA+Plus+Cyanine+3/bio_rxiv__2025__03__03__641311-192-18-23
Average 96 stars, based on 1 article reviews
red dye tsa cy3 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Biotium cyanine dye dioc16 3
Localised microcapsule distribution within the targeted somatosensory cortex and microcapsule uptake by cortical neurons in vivo. (A–B) Image of a dispersed suspension of PAH/PSS-based microcapsules (RITC fluorescence) and cytotoxicity test (B) showing no changes in cell viability for differentiating N2A cells over time of incubation with microcapsules. Data are mean and s.d. Scale bar: 2 μm. (C–D) 2 PE images of microcapsule distribution (RITC fluorescence, red channel) within the somatosensory cortex 24–48 h after stereotaxic cerebral injection of PAH/PSS-based microcapsules in vivo . Note the injection site and localised microcapsule distribution within the targeted region (∼350–400 μm from the injection site) in C and D (top image). Lower images in D show individual neurons with intracellular microcapsules in the somatosensory barrel cortex. Images are merged red (RITC fluorescence) and green channels (lipophilic cyanine dye <t>DIOC16,</t> membrane staining). Images are average Z-profiles (3–5 focal planes); λ x 2PE = 820 nm.
Cyanine Dye Dioc16 3, supplied by Biotium, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyanine-3+dyes/DiOC16(3)/pmc11815287-82-14-21
Average 94 stars, based on 1 article reviews
cyanine dye dioc16 3 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Amersham Life Sciences Inc cyanine 3 maleimide mono-reactive dye
Localised microcapsule distribution within the targeted somatosensory cortex and microcapsule uptake by cortical neurons in vivo. (A–B) Image of a dispersed suspension of PAH/PSS-based microcapsules (RITC fluorescence) and cytotoxicity test (B) showing no changes in cell viability for differentiating N2A cells over time of incubation with microcapsules. Data are mean and s.d. Scale bar: 2 μm. (C–D) 2 PE images of microcapsule distribution (RITC fluorescence, red channel) within the somatosensory cortex 24–48 h after stereotaxic cerebral injection of PAH/PSS-based microcapsules in vivo . Note the injection site and localised microcapsule distribution within the targeted region (∼350–400 μm from the injection site) in C and D (top image). Lower images in D show individual neurons with intracellular microcapsules in the somatosensory barrel cortex. Images are merged red (RITC fluorescence) and green channels (lipophilic cyanine dye <t>DIOC16,</t> membrane staining). Images are average Z-profiles (3–5 focal planes); λ x 2PE = 820 nm.
Cyanine 3 Maleimide Mono Reactive Dye, supplied by Amersham Life Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyanine-3+dyes/cy3+maleimide/10__3390_slash_cells13231967-69-7-13
Average 90 stars, based on 1 article reviews
cyanine 3 maleimide mono-reactive dye - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Amersham Life Sciences Inc cyanine 3 (cy3) maleimide mono-reactive dye
SPRY2 reduces the number of FGFR1 and FGF2 vesicles and their colocalization in U251 and SF126 cells. ( A ) U251 control cells with low endogenous SPRY2 level and U251 cells with SPRY2-OE were transfected with FGFR1 fused to enhanced green fluorescent protein (FGFR1-EGFP) and treated with cyanine 3-labeled FGF2 <t>(FGF2-Cy3)</t> for 30 min. Whole-cell analysis of confocal images revealed a reduction in FGFR1 (green) and FGF2 (red) vesicles per cell and their reduced colocalization (yellow) in response to SPRY2-OE. N = 18 experiments, mean ± SEM. *** p < 0.001, **** p < 0.0001. ( B ) SF126 control cells with high endogenous SPRY2 content and SF126 cells with shSPRY2 were transfected with FGFR1-EGFP and treated with FGF2-Cy3 for 30 min. Whole-cell analysis of confocal images revealed an increase in FGFR1 (green) and FGF2 (red) vesicles per cell as well as their enhanced colocalization (yellow) in response to shSPRY2. N = 15 experiments, mean ± SEM. *** p < 0.001, **** p < 0.0001. White, bold arrowheads indicate cell surface localization of FGFR1 and FGF2. Yellow arrowheads mark internalized FGFR1 vesicles colocalizing with FGF2. Scale bar = 4 µm.
Cyanine 3 (Cy3) Maleimide Mono Reactive Dye, supplied by Amersham Life Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyanine-3+dyes/cy3+maleimide/pmc11639775-83-7-13
Average 90 stars, based on 1 article reviews
cyanine 3 (cy3) maleimide mono-reactive dye - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Qiagen fluorescent dye cyanine-3-ctp
SPRY2 reduces the number of FGFR1 and FGF2 vesicles and their colocalization in U251 and SF126 cells. ( A ) U251 control cells with low endogenous SPRY2 level and U251 cells with SPRY2-OE were transfected with FGFR1 fused to enhanced green fluorescent protein (FGFR1-EGFP) and treated with cyanine 3-labeled FGF2 <t>(FGF2-Cy3)</t> for 30 min. Whole-cell analysis of confocal images revealed a reduction in FGFR1 (green) and FGF2 (red) vesicles per cell and their reduced colocalization (yellow) in response to SPRY2-OE. N = 18 experiments, mean ± SEM. *** p < 0.001, **** p < 0.0001. ( B ) SF126 control cells with high endogenous SPRY2 content and SF126 cells with shSPRY2 were transfected with FGFR1-EGFP and treated with FGF2-Cy3 for 30 min. Whole-cell analysis of confocal images revealed an increase in FGFR1 (green) and FGF2 (red) vesicles per cell as well as their enhanced colocalization (yellow) in response to shSPRY2. N = 15 experiments, mean ± SEM. *** p < 0.001, **** p < 0.0001. White, bold arrowheads indicate cell surface localization of FGFR1 and FGF2. Yellow arrowheads mark internalized FGFR1 vesicles colocalizing with FGF2. Scale bar = 4 µm.
Fluorescent Dye Cyanine 3 Ctp, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyanine-3+dyes/fluorescent+dye+cyanine+3+ctp/pmc11590579-43-7-15
Average 90 stars, based on 1 article reviews
fluorescent dye cyanine-3-ctp - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Localised microcapsule distribution within the targeted somatosensory cortex and microcapsule uptake by cortical neurons in vivo. (A–B) Image of a dispersed suspension of PAH/PSS-based microcapsules (RITC fluorescence) and cytotoxicity test (B) showing no changes in cell viability for differentiating N2A cells over time of incubation with microcapsules. Data are mean and s.d. Scale bar: 2 μm. (C–D) 2 PE images of microcapsule distribution (RITC fluorescence, red channel) within the somatosensory cortex 24–48 h after stereotaxic cerebral injection of PAH/PSS-based microcapsules in vivo . Note the injection site and localised microcapsule distribution within the targeted region (∼350–400 μm from the injection site) in C and D (top image). Lower images in D show individual neurons with intracellular microcapsules in the somatosensory barrel cortex. Images are merged red (RITC fluorescence) and green channels (lipophilic cyanine dye DIOC16, membrane staining). Images are average Z-profiles (3–5 focal planes); λ x 2PE = 820 nm.

Journal: Materials Today Bio

Article Title: Brain neurons internalise polymeric micron-sized capsules: Insights from in vitro and in vivo studies

doi: 10.1016/j.mtbio.2025.101493

Figure Lengend Snippet: Localised microcapsule distribution within the targeted somatosensory cortex and microcapsule uptake by cortical neurons in vivo. (A–B) Image of a dispersed suspension of PAH/PSS-based microcapsules (RITC fluorescence) and cytotoxicity test (B) showing no changes in cell viability for differentiating N2A cells over time of incubation with microcapsules. Data are mean and s.d. Scale bar: 2 μm. (C–D) 2 PE images of microcapsule distribution (RITC fluorescence, red channel) within the somatosensory cortex 24–48 h after stereotaxic cerebral injection of PAH/PSS-based microcapsules in vivo . Note the injection site and localised microcapsule distribution within the targeted region (∼350–400 μm from the injection site) in C and D (top image). Lower images in D show individual neurons with intracellular microcapsules in the somatosensory barrel cortex. Images are merged red (RITC fluorescence) and green channels (lipophilic cyanine dye DIOC16, membrane staining). Images are average Z-profiles (3–5 focal planes); λ x 2PE = 820 nm.

Article Snippet: For live-cell 2 PE imaging, neurons were labelled with one of the lipophilic dyes, cyanine dye DIOC16(3) or carbocyanine dye DID (Biotium, UK), to provide a stable labelling of the lipid bilayer membranes.

Techniques: In Vivo, Suspension, Fluorescence, Incubation, Injection, Membrane, Staining

Long-term assessment of microcapsules in the somatosensory cortex in vivo. (A) 2 PE microscopy in vivo visualised PAH/PSS-based microcapsules (RITC fluorescence, red signal) across the targeted somatosensory cortex 5–7 days after stereotaxic cerebral injection. The left image shows an overview of microcapsule scatter; the right image notes sparsely distributed microcapsules across individual fibres. Images are merged red channel (RITC, microcapsule shell) and green channel (lipophilic cyanine dye DIOC16, cell membrane staining). (B) Images of the somatosensory barrel cortex (approximately −200 μm from the pia), showing individual neurons with intracellular microcapsules. Images are merged red (RITC fluorescence) and green channels (DIOC16, membrane staining); λ x 2PE = 820 nm.

Journal: Materials Today Bio

Article Title: Brain neurons internalise polymeric micron-sized capsules: Insights from in vitro and in vivo studies

doi: 10.1016/j.mtbio.2025.101493

Figure Lengend Snippet: Long-term assessment of microcapsules in the somatosensory cortex in vivo. (A) 2 PE microscopy in vivo visualised PAH/PSS-based microcapsules (RITC fluorescence, red signal) across the targeted somatosensory cortex 5–7 days after stereotaxic cerebral injection. The left image shows an overview of microcapsule scatter; the right image notes sparsely distributed microcapsules across individual fibres. Images are merged red channel (RITC, microcapsule shell) and green channel (lipophilic cyanine dye DIOC16, cell membrane staining). (B) Images of the somatosensory barrel cortex (approximately −200 μm from the pia), showing individual neurons with intracellular microcapsules. Images are merged red (RITC fluorescence) and green channels (DIOC16, membrane staining); λ x 2PE = 820 nm.

Article Snippet: For live-cell 2 PE imaging, neurons were labelled with one of the lipophilic dyes, cyanine dye DIOC16(3) or carbocyanine dye DID (Biotium, UK), to provide a stable labelling of the lipid bilayer membranes.

Techniques: In Vivo, Microscopy, Fluorescence, Injection, Membrane, Staining

SPRY2 reduces the number of FGFR1 and FGF2 vesicles and their colocalization in U251 and SF126 cells. ( A ) U251 control cells with low endogenous SPRY2 level and U251 cells with SPRY2-OE were transfected with FGFR1 fused to enhanced green fluorescent protein (FGFR1-EGFP) and treated with cyanine 3-labeled FGF2 (FGF2-Cy3) for 30 min. Whole-cell analysis of confocal images revealed a reduction in FGFR1 (green) and FGF2 (red) vesicles per cell and their reduced colocalization (yellow) in response to SPRY2-OE. N = 18 experiments, mean ± SEM. *** p < 0.001, **** p < 0.0001. ( B ) SF126 control cells with high endogenous SPRY2 content and SF126 cells with shSPRY2 were transfected with FGFR1-EGFP and treated with FGF2-Cy3 for 30 min. Whole-cell analysis of confocal images revealed an increase in FGFR1 (green) and FGF2 (red) vesicles per cell as well as their enhanced colocalization (yellow) in response to shSPRY2. N = 15 experiments, mean ± SEM. *** p < 0.001, **** p < 0.0001. White, bold arrowheads indicate cell surface localization of FGFR1 and FGF2. Yellow arrowheads mark internalized FGFR1 vesicles colocalizing with FGF2. Scale bar = 4 µm.

Journal: Cells

Article Title: Sprouty2 Regulates Endocytosis and Degradation of Fibroblast Growth Factor Receptor 1 in Glioblastoma Cells

doi: 10.3390/cells13231967

Figure Lengend Snippet: SPRY2 reduces the number of FGFR1 and FGF2 vesicles and their colocalization in U251 and SF126 cells. ( A ) U251 control cells with low endogenous SPRY2 level and U251 cells with SPRY2-OE were transfected with FGFR1 fused to enhanced green fluorescent protein (FGFR1-EGFP) and treated with cyanine 3-labeled FGF2 (FGF2-Cy3) for 30 min. Whole-cell analysis of confocal images revealed a reduction in FGFR1 (green) and FGF2 (red) vesicles per cell and their reduced colocalization (yellow) in response to SPRY2-OE. N = 18 experiments, mean ± SEM. *** p < 0.001, **** p < 0.0001. ( B ) SF126 control cells with high endogenous SPRY2 content and SF126 cells with shSPRY2 were transfected with FGFR1-EGFP and treated with FGF2-Cy3 for 30 min. Whole-cell analysis of confocal images revealed an increase in FGFR1 (green) and FGF2 (red) vesicles per cell as well as their enhanced colocalization (yellow) in response to shSPRY2. N = 15 experiments, mean ± SEM. *** p < 0.001, **** p < 0.0001. White, bold arrowheads indicate cell surface localization of FGFR1 and FGF2. Yellow arrowheads mark internalized FGFR1 vesicles colocalizing with FGF2. Scale bar = 4 µm.

Article Snippet: Subsequently, recombinant FGF2 was fluorescently labeled with cyanine 3 (Cy3) maleimide mono-reactive dye (Amersham, Darmstadt, Germany) according to the manufacturer’s protocol.

Techniques: Control, Transfection, Labeling, Cell Analysis

SPRY2 inhibits colocalization of clathrin with FGFR1 and FGF2 in U251 and SF126 cells. ( A ) U251 control cells with low endogenous SPRY2 level and U251 cells with SPRY2-OE were transfected with FGFR1-EGFP, treated with FGF2-Cy3 for 30 min, and immunostained against clathrin. Whole-cell analysis of confocal images revealed no change in the number of clathrin vesicles per cell (blue) after SPRY2-OE. The colocalization of clathrin (blue) with FGFR1 (green; colocalization with clathrin = turquoise) and FGF2 (red; colocalization with clathrin = magenta) was reduced in response to SPRY2-OE. N = 6 experiments, mean ± SEM. * p < 0.05. ( B ) SF126 control cells with high endogenous SPRY2 content and SF126 cells with shSPRY2 were transfected with FGFR1-EGFP, treated with FGF2-Cy3 for 30 min, and immunostained against clathrin. The number of clathrin vesicles per cell (blue) was not altered with shSPRY2. The colocalization of clathrin (blue) with FGFR1 (green; colocalization with clathrin = turquoise) and FGF2 (red; colocalization with clathrin = magenta) was enhanced with shSPRY2. N = 5 experiments, mean ± SEM. ** p < 0.01. White, bold arrowheads indicate cell surface localization of FGFR1 and FGF2. Yellow arrowheads mark internalized FGFR1 and FGF2 vesicles colocalizing with clathrin. Scale bar = 4 µm.

Journal: Cells

Article Title: Sprouty2 Regulates Endocytosis and Degradation of Fibroblast Growth Factor Receptor 1 in Glioblastoma Cells

doi: 10.3390/cells13231967

Figure Lengend Snippet: SPRY2 inhibits colocalization of clathrin with FGFR1 and FGF2 in U251 and SF126 cells. ( A ) U251 control cells with low endogenous SPRY2 level and U251 cells with SPRY2-OE were transfected with FGFR1-EGFP, treated with FGF2-Cy3 for 30 min, and immunostained against clathrin. Whole-cell analysis of confocal images revealed no change in the number of clathrin vesicles per cell (blue) after SPRY2-OE. The colocalization of clathrin (blue) with FGFR1 (green; colocalization with clathrin = turquoise) and FGF2 (red; colocalization with clathrin = magenta) was reduced in response to SPRY2-OE. N = 6 experiments, mean ± SEM. * p < 0.05. ( B ) SF126 control cells with high endogenous SPRY2 content and SF126 cells with shSPRY2 were transfected with FGFR1-EGFP, treated with FGF2-Cy3 for 30 min, and immunostained against clathrin. The number of clathrin vesicles per cell (blue) was not altered with shSPRY2. The colocalization of clathrin (blue) with FGFR1 (green; colocalization with clathrin = turquoise) and FGF2 (red; colocalization with clathrin = magenta) was enhanced with shSPRY2. N = 5 experiments, mean ± SEM. ** p < 0.01. White, bold arrowheads indicate cell surface localization of FGFR1 and FGF2. Yellow arrowheads mark internalized FGFR1 and FGF2 vesicles colocalizing with clathrin. Scale bar = 4 µm.

Article Snippet: Subsequently, recombinant FGF2 was fluorescently labeled with cyanine 3 (Cy3) maleimide mono-reactive dye (Amersham, Darmstadt, Germany) according to the manufacturer’s protocol.

Techniques: Control, Transfection, Cell Analysis

SPRY2 inhibits colocalization of caveolin-1 with FGFR1 and FGF2 in U251 and SF126 cells and reduces caveolin-1 vesicles. ( A ) U251 control cells with low endogenous SPRY2 level and U251 cells with SPRY2-OE were transfected with FGFR1-EGFP, treated with FGF2-Cy3 for 30 min, and immunostained against caveolin-1. Whole-cell analysis of confocal images revealed a reduction in the number of caveolin-1 vesicles per cell (blue) after SPRY2-OE. The colocalization of caveolin-1 (blue) with FGFR1 (green; colocalization with caveolin-1 = turquoise) and FGF2 (red; colocalization with caveolin-1 = magenta) was reduced in response to SPRY2-OE. N = 6 experiments, mean ± SEM. ** p < 0.01, *** p < 0.001. ( B ) SF126 control cells with high endogenous SPRY2 content and SF126 cells with shSPRY2 were transfected with FGFR1-EGFP, treated with FGF2-Cy3 for 30 min, and immunostained against caveolin-1. The number of caveolin-1 vesicles per cell (blue) was slightly but not significantly enhanced with shSPRY2. The colocalization of caveolin-1 (blue) with FGFR1 (green; colocalization with caveolin-1 = turquoise) and FGF2 (red; colocalization with caveolin-1 = magenta) was enhanced with shSPRY2. N = 5 experiments, mean ± SEM. * p < 0.05. White, bold arrowheads indicate cell surface localization of FGFR1 and FGF2. Yellow arrowheads mark internalized FGFR1 and FGF2 vesicles colocalizing with caveolin-1. Scale bar = 4 µm.

Journal: Cells

Article Title: Sprouty2 Regulates Endocytosis and Degradation of Fibroblast Growth Factor Receptor 1 in Glioblastoma Cells

doi: 10.3390/cells13231967

Figure Lengend Snippet: SPRY2 inhibits colocalization of caveolin-1 with FGFR1 and FGF2 in U251 and SF126 cells and reduces caveolin-1 vesicles. ( A ) U251 control cells with low endogenous SPRY2 level and U251 cells with SPRY2-OE were transfected with FGFR1-EGFP, treated with FGF2-Cy3 for 30 min, and immunostained against caveolin-1. Whole-cell analysis of confocal images revealed a reduction in the number of caveolin-1 vesicles per cell (blue) after SPRY2-OE. The colocalization of caveolin-1 (blue) with FGFR1 (green; colocalization with caveolin-1 = turquoise) and FGF2 (red; colocalization with caveolin-1 = magenta) was reduced in response to SPRY2-OE. N = 6 experiments, mean ± SEM. ** p < 0.01, *** p < 0.001. ( B ) SF126 control cells with high endogenous SPRY2 content and SF126 cells with shSPRY2 were transfected with FGFR1-EGFP, treated with FGF2-Cy3 for 30 min, and immunostained against caveolin-1. The number of caveolin-1 vesicles per cell (blue) was slightly but not significantly enhanced with shSPRY2. The colocalization of caveolin-1 (blue) with FGFR1 (green; colocalization with caveolin-1 = turquoise) and FGF2 (red; colocalization with caveolin-1 = magenta) was enhanced with shSPRY2. N = 5 experiments, mean ± SEM. * p < 0.05. White, bold arrowheads indicate cell surface localization of FGFR1 and FGF2. Yellow arrowheads mark internalized FGFR1 and FGF2 vesicles colocalizing with caveolin-1. Scale bar = 4 µm.

Article Snippet: Subsequently, recombinant FGF2 was fluorescently labeled with cyanine 3 (Cy3) maleimide mono-reactive dye (Amersham, Darmstadt, Germany) according to the manufacturer’s protocol.

Techniques: Control, Transfection, Cell Analysis

SPRY2 decreases transferrin-647 uptake and colocalization of transferrin with FGFR1 and FGF2 in U251 and SF126 cells. ( A ) U251 control cells with low endogenous SPRY2 level and U251 cells with SPRY2-OE were transfected with FGFR1-EGFP and treated with FGF2-Cy3 for 30 min and with transferrin-647 for 15 min. Whole-cell analysis of confocal images revealed a reduction in the uptake of transferrin vesicles per cell (blue) after SPRY2-OE. The colocalization of transferrin (blue) with FGFR1 (green; colocalization with transferrin = turquoise) and FGF2 (red; colocalization with transferrin = magenta) was also reduced in response to SPRY2-OE. N = 6 experiments, mean ± SEM. ** p < 0.01, *** p < 0.001. ( B ) SF126 control cells with high endogenous SPRY2 content and SF126 cells with shSPRY2 were transfected with FGFR1-EGFP and treated with FGF2-Cy3 for 30 min and with transferrin-647 for 15 min. The uptake of transferrin vesicles per cell (blue) was increased with shSPRY2, and the colocalization of transferrin (blue) with FGFR1 (green; colocalization with transferrin = turquoise) and FGF2 (red; colocalization with transferrin = magenta) was enhanced with shSPRY2. N = 5 experiments, mean ± SEM. * p < 0.05, ** p < 0.01. White, bold arrowheads indicate cell surface localization of FGFR1 and FGF2. Yellow arrowheads mark FGFR1 and FGF2 vesicles colocalizing with transferrin. Scale bar = 4 µm.

Journal: Cells

Article Title: Sprouty2 Regulates Endocytosis and Degradation of Fibroblast Growth Factor Receptor 1 in Glioblastoma Cells

doi: 10.3390/cells13231967

Figure Lengend Snippet: SPRY2 decreases transferrin-647 uptake and colocalization of transferrin with FGFR1 and FGF2 in U251 and SF126 cells. ( A ) U251 control cells with low endogenous SPRY2 level and U251 cells with SPRY2-OE were transfected with FGFR1-EGFP and treated with FGF2-Cy3 for 30 min and with transferrin-647 for 15 min. Whole-cell analysis of confocal images revealed a reduction in the uptake of transferrin vesicles per cell (blue) after SPRY2-OE. The colocalization of transferrin (blue) with FGFR1 (green; colocalization with transferrin = turquoise) and FGF2 (red; colocalization with transferrin = magenta) was also reduced in response to SPRY2-OE. N = 6 experiments, mean ± SEM. ** p < 0.01, *** p < 0.001. ( B ) SF126 control cells with high endogenous SPRY2 content and SF126 cells with shSPRY2 were transfected with FGFR1-EGFP and treated with FGF2-Cy3 for 30 min and with transferrin-647 for 15 min. The uptake of transferrin vesicles per cell (blue) was increased with shSPRY2, and the colocalization of transferrin (blue) with FGFR1 (green; colocalization with transferrin = turquoise) and FGF2 (red; colocalization with transferrin = magenta) was enhanced with shSPRY2. N = 5 experiments, mean ± SEM. * p < 0.05, ** p < 0.01. White, bold arrowheads indicate cell surface localization of FGFR1 and FGF2. Yellow arrowheads mark FGFR1 and FGF2 vesicles colocalizing with transferrin. Scale bar = 4 µm.

Article Snippet: Subsequently, recombinant FGF2 was fluorescently labeled with cyanine 3 (Cy3) maleimide mono-reactive dye (Amersham, Darmstadt, Germany) according to the manufacturer’s protocol.

Techniques: Control, Transfection, Cell Analysis